Constitutive expression of stromal derived factor-1 by mucosal epithelia and its role in HIV transmission and propagation

被引:169
作者
Agace, WW
Amara, A
Roberts, AI
Pablos, JL
Thelen, S
Uguccioni, M
Li, XY
Marsal, J
Arenzana-Seisdedos, F
Delaunay, T
Ebert, EC
Moser, B
Parker, CM
机构
[1] Brigham & Womens Hosp, Div Rheumatol Allergy & Immunol, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Boston, MA 02115 USA
[3] Inst Pasteur, Unite Immunol Virale, F-75724 Paris, France
[4] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Med, New Brunswick, NJ 08903 USA
[5] Hosp 12 Octubre, Serv Reumatol, Ctr Invest, E-28041 Madrid, Spain
[6] Univ Bern, Theodor Kocher Inst, CH-3000 Bern 9, Switzerland
[7] INRA, Pathol Vegetale Stn, F-33883 Villenave Dornon, France
关键词
D O I
10.1016/S0960-9822(00)00380-8
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
HIV particles that use the chemokine receptor CXCR4 as a coreceptor for entry into cells (X4-HIV) inefficiently transmit infection across mucosal surfaces [1], despite their presence in seminal fluid and mucosal secretions from infected individuals [2-4]. In addition, although intestinal lymphocytes are susceptible to infection with either X4-HIV particles or particles that use the chemokine receptor CCR5 for viral entry (R5-HIV) during ex vivo culture [5], only systemic inoculation of RE-chimeric simian-HIV (S-HIV) results in a rapid loss of CD4(+) intestinal lymphocytes in macaques [6]. The mechanisms underlying the inefficient capacity of X4-HIV to transmit infection across mucosal surfaces and to infect intestinal lymphocytes in vivo have remained elusive. The CCR5 ligands RANTES, MIP-1 alpha and MIP-1 beta suppress infection by R5-HIV-1 particles via Induction of CCR5 internalization, and individuals whose peripheral blood lymphocytes produce high levels of these chemokines are relatively resistant to infection [7-9]. Here, we show that the CXCR4 ligand stromal derived factor-1 (SDF-1) is constitutively expressed by mucosal epithelial cells at sites of HIV transmission and propagation. Furthermore, CXCR4 is selectively downmodulated on intestinal lymphocytes within the setting of prominent SDF-1 expression. We postulate that mucosally derived SDF-1 continuously downmodulates CXCR4 on resident HIV target cells, thereby reducing the transmission and propagation of X4-HIV at mucosal sites. Moreover, such a mechanism could contribute to the delayed emergence of X4 isolates, which predominantly occurs during the later stages of the HIV infection.
引用
收藏
页码:325 / 328
页数:4
相关论文
共 27 条
[1]   Stromal cell-derived factor-1α associates with heparan sulfates through the first β-strand of the chemokine [J].
Amara, A ;
Lorthioir, O ;
Valenzuela, A ;
Magerus, A ;
Thelen, M ;
Montes, M ;
Virelizier, JL ;
Delepierre, M ;
Baleux, F ;
Lortat-Jacob, H ;
Arenzana-Seisdedos, F .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (34) :23916-23925
[2]   HIV coreceptor downregulation as antiviral principle: SDF-1 alpha-dependent internalization of the chemokine receptor CXCR4 contributes to inhibition of HIV replication [J].
Amara, A ;
LeGall, S ;
Schwartz, O ;
Salamero, J ;
Montes, M ;
Loetscher, P ;
Baggiolini, M ;
Virelizier, JL ;
ArenzanaSeisdedos, F .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (01) :139-146
[3]  
Bermejo M, 1998, EUR J IMMUNOL, V28, P3192
[4]   Differential regulation of HIV-1 fusion cofactor expression by CD28 costimulation of CD4(+) T cells [J].
Carroll, RG ;
Riley, JL ;
Levine, BL ;
Feng, Y ;
Kaushal, S ;
Ritchey, DW ;
Bernstein, W ;
Weislow, OS ;
Brown, CR ;
Berger, EA ;
June, CH ;
StLouis, DC .
SCIENCE, 1997, 276 (5310) :273-276
[5]   Human immunodeficiency virus type 1 populations in blood and semen [J].
Delwart, EL ;
Mullins, JI ;
Gupta, P ;
Learn, GH ;
Holodniy, M ;
Katzenstein, D ;
Walker, BD ;
Singh, MK .
JOURNAL OF VIROLOGY, 1998, 72 (01) :617-623
[6]   PROLIFERATIVE RESPONSES OF HUMAN INTRAEPITHELIAL LYMPHOCYTES TO VARIOUS T-CELL STIMULI [J].
EBERT, EC .
GASTROENTEROLOGY, 1989, 97 (06) :1372-1381
[7]   Host factors and the pathogenesis of HIV-induced disease [J].
Fauci, AS .
NATURE, 1996, 384 (6609) :529-534
[8]  
Galli G, 1998, EUR J IMMUNOL, V28, P3280, DOI 10.1002/(SICI)1521-4141(199810)28:10<3280::AID-IMMU3280>3.0.CO
[9]  
2-M
[10]  
Garzino-Demo A, 1998, AIDS RES HUM RETROV, V14, pS177